Clinical Trial Update: Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing chiglitazar with sitagliptin in type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED